Cargando…

D‐cycloserine‐augmented one‐session treatment of specific phobias in children and adolescents

BACKGROUND: D‐Cycloserine has potential to enhance exposure therapy outcomes. The current study presents a preliminary randomized, placebo‐controlled double‐blind pilot trial of DCS‐augmented one‐session treatment (OST) for youth (7–14 years) with specific phobia. A secondary aim of this pilot study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Farrell, Lara J., Waters, Allison M., Oar, Ella L., Tiralongo, Evelin, Garbharran, Vinay, Alston‐Knox, Clair, McConnell, Harry, Collings, Nigel, Zimmer‐Gembeck, Melanie, Donovan, Caroline L., Testa, Chris, Storch, Eric A., Ollendick, Thomas H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991588/ https://www.ncbi.nlm.nih.gov/pubmed/30106248 http://dx.doi.org/10.1002/brb3.984

Ejemplares similares

Efficacy of D‐cycloserine augmented brief intensive cognitive‐behavioural therapy for paediatric obsessive‐compulsive disorder: A randomised clinical trial
por: Farrell, Lara J., et al.
Publicado: (2022)

Bibliotherapy for Specific Phobias of Dogs in Young Children: A Pilot Study
por: Radtke, Sarah R., et al.
Publicado: (2022)

Cycloserine induced mania
por: Bakhla, Ajay Kumar, et al.
Publicado: (2013)

Cycloserine induced psychosis with hepatic dysfunction
por: Tandon, Vishal R., et al.
Publicado: (2015)

Phobias
por: Emerson, Joyce
Publicado: (1968)

Neuroleptic malignant syndrome in cycloserine-induced psychosis
por: Sawant, Neena S., et al.
Publicado: (2015)

Cycloserine Population Pharmacokinetics and Pharmacodynamics in Patients with Tuberculosis
por: Alghamdi, Wael A., et al.
Publicado: (2019)

Deterioration of Cycloserine in Drug Susceptibility Testing of Mycobacterium
por: Wang, Ruibai, et al.
Publicado: (2022)

D-Cycloserine in Neuropsychiatric Diseases: A Systematic Review
por: Schade, Sebastian, et al.
Publicado: (2015)

Fears and Phobias
por: Freeman, Hugh
Publicado: (1969)

Fear acquisition and extinction in offspring of mothers with anxiety and depressive disorders
por: Waters, Allison M., et al.
Publicado: (2013)

d-Cycloserine destruction by alanine racemase and the limit of irreversible inhibition
por: de Chiara, Cesira, et al.
Publicado: (2020)

Phobias: their nature and control,
por: Rachman, Stanley
Publicado: (1968)

Truancy—Or School Phobia?
por: Ratcliffe, T. A.
Publicado: (1960)

Vr exposure in cbt is effective and efficacious treatment for simple phobia (flight phobia)
por: D’Ambrosio, A., et al.
Publicado: (2021)

Closing the Gap for Children with OCD: A Staged-Care Model of Cognitive Behavioural Therapy with Exposure and Response Prevention
por: Farrell, Lara J., et al.
Publicado: (2023)

One-session treatment for specific phobias: Barriers, facilitators and acceptability as perceived by children & young people, parents, and clinicians
por: Hayward, Emily, et al.
Publicado: (2022)

The NMDA Agonist D-Cycloserine Facilitates Fear Memory Consolidation in Humans
por: Kalisch, Raffael, et al.
Publicado: (2009)

D-Cycloserine as an augmentation strategy for cognitive behavioral therapy of anxiety disorders
por: Hofmann, Stefan G, et al.
Publicado: (2013)

Role of Alanine Racemase Mutations in Mycobacterium tuberculosis d-Cycloserine Resistance
por: Nakatani, Yoshio, et al.
Publicado: (2017)

D-cycloserine improves synaptic transmission in an animal mode of Rett syndrome
por: Na, Elisa S., et al.
Publicado: (2017)

Neuropsychiatric toxicity and cycloserine concentrations during treatment for multidrug-resistant tuberculosis
por: Court, Richard, et al.
Publicado: (2021)

Non-significant p-values? Strategies to understand and better determine the importance of effects and interactions in logistic regression
por: Vakhitova, Zarina I., et al.
Publicado: (2018)

Topical Corticosteroid Addiction and Phobia
por: Ghosh, Aparajita, et al.
Publicado: (2014)

Nausea in Specific Phobia of Vomiting
por: Höller, Yvonne, et al.
Publicado: (2013)

Neurobiology of fear and specific phobias
por: Garcia, René
Publicado: (2017)

Phobia of the Supernatural: A Distinct but Poorly Recognized Specific Phobia With an Adverse Impact on Daily Living
por: de Oliveira-Souza, Ricardo
Publicado: (2018)

The NMDA receptor partial agonist d-cycloserine does not enhance motor learning
por: Günthner, Jan, et al.
Publicado: (2016)

d-Cycloserine enhances durability of social skills training in autism spectrum disorder
por: Wink, Logan K., et al.
Publicado: (2017)

Correction: D-cycloserine improves synaptic transmission in an animal mode of Rett syndrome
por: Na, Elisa S., et al.
Publicado: (2018)

D-cycloserine in Schizophrenia: New Strategies for Improving Clinical Outcomes by Enhancing Plasticity
por: Goff, Donald C.
Publicado: (2017)

Cycloserine for treatment of multidrug-resistant tuberculosis: a retrospective cohort study in China
por: Li, Yang, et al.
Publicado: (2019)

Effect of d-cycloserine on fear extinction training in adults with social anxiety disorder
por: Hofmann, Stefan G., et al.
Publicado: (2019)

Substrate Reduction Therapy for Krabbe Disease: Exploring the Repurposing of the Antibiotic D-Cycloserine
por: LeVine, Steven M., et al.
Publicado: (2022)

The effect of ketamine and D-cycloserine on the high frequency resting EEG spectrum in humans
por: Nottage, J. F., et al.
Publicado: (2022)

Evaluation of the Effectiveness of One- and Multi-Session Exposure-Based Treatments in Reducing Biological and Psychological Responses to Rat Phobia Among Students
por: Hemyari, Camellia, et al.
Publicado: (2020)

Panic. Facing Fears, Phobias, and Anxiety
por: Vogel, Leslie R.
Publicado: (1985)

Treatment of specific phobia in older adults
por: Pachana, Nancy A, et al.
Publicado: (2007)

Phobias in Poetry: Coleridge′s Ancient Mariner
por: Singh, Satendra, et al.
Publicado: (2012)

Processing of emotional faces in social phobia
por: Staugaard, Søren Risløv, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_oem75a6e1fta7nl0it92ied8b3